NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NA
Post# of 194
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the Virtual Investor 2023 “Companies to Watch” event. Climaco’s presentation is scheduled to take place beginning at 10 a.m. ET on Wednesday, Jan. 18, 2023. A live video webcast of the presentation will be available on the Events page of CNS Pharmaceuticals’ website, and a replay will be available two hours following the live presentation and accessible for 90 days.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer